Andrew Garufi

FDA investigator

Appears on 11 documents from 2015 to 2025, mostly at sites in New York. Most often cites receiving, in-process, and finished device acceptance (21 CFR 820.80(b)).

11
Documents on file
3.8
Observations per 483
2015
First seen
2025
Most recent

What they cite most

From 42 observations

Activity by year

2015: 2, 2016: 1, 2017: 1, 2018: 2, 2021: 1, 2023: 2, 2024: 1, 2025: 1

Where

New York 10 · Connecticut 1

Is Andrew Garufi coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

11 documents, newest first
FirmOpen
483 WS Audiology USA Inc.Oct 20, 2025 · Hauppauge, New York
483 Prove Labs IncApr 17, 2024 · Brooklyn, New York
483 Banyan USA LLCSep 12, 2023 · Hauppauge, New York
483 Falck Medical IncorporatedAug 21, 2023 · Mystic, Connecticut
483 Aerolase Corp.May 20, 2021 · Tarrytown, New York
483 Accurate Surgical & ScientificJul 18, 2018 · Westbury, New York
483 Advanced Monitored CaregivingMar 29, 2018 · New York, New York

About this profile

What does Andrew Garufi inspect?

Andrew Garufi appears on 11 documents on file covering 11 sites, mostly in New York.

What do they cite most often?

21 CFR 820.80(b) (receiving, in-process, and finished device acceptance), followed by 21 CFR 820.50(a) and 21 CFR 820.198(a).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Andrew Garufi is dated Oct 20, 2025.